| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.011 | 0.9 |